Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
NASDAQ: SHPH · Real-Time Price · USD
0.840
-0.070 (-7.69%)
At close: Jan 17, 2025, 4:00 PM
0.888
+0.048 (5.77%)
After-hours: Jan 17, 2025, 4:42 PM EST
SHPH Employees
Shuttle Pharmaceuticals Holdings had 8 employees as of December 31, 2023. The number of employees increased by 1 or 14.29% compared to the previous year.
Employees
8
Change (1Y)
1
Growth (1Y)
14.29%
Revenue / Employee
n/a
Profits / Employee
-$1,148,354
Market Cap
3.08M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 8 | 1 | 14.29% |
| Dec 31, 2022 | 7 | 2 | 40.00% |
| Dec 31, 2021 | 5 | 0 | - |
| Dec 31, 2020 | 5 | -1 | -16.67% |
| Dec 31, 2016 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
SHPH News
- 13 days ago - Shuttle Pharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025 - GlobeNewsWire
- 7 weeks ago - Shuttle Pharma Expands Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma as UVA Cancer Center Doses Its First Patient - GlobeNewsWire
- 2 months ago - Shuttle Pharma Provides Third Quarter 2024 Corporate Update - GlobeNewsWire
- 2 months ago - Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules - GlobeNewsWire
- 3 months ago - Shuttle Pharma Completes Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma - GlobeNewsWire
- 4 months ago - Shuttle Pharma Expands Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma - GlobeNewsWire
- 4 months ago - Shuttle Pharma Provides Second Quarter 2024 Corporate Update - GlobeNewsWire
- 5 months ago - Shuttle Pharma Receives Notice of Nasdaq Non-Compliance with Listing Rule 5250(c)(1) - GlobeNewsWire